Stock MTD METTLER-TOLEDO INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Mettler-Toledo International, Inc.

Equities

MTD

US5926881054

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
1,238 USD +0.42% Intraday chart for Mettler-Toledo International, Inc. +4.17% +2.07%
Apr. 22 Baird Adjusts Price Target on Mettler-Toledo International to $1,212 From $1,192, Neutral Rating Kept MT
Mar. 06 Mettler Toledo International Inc/ Insider Sold Shares Worth $511,492, According to a Recent SEC Filing MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 19,320 27,118 39,011 32,225 26,302 26,480 - -
Enterprise Value (EV) 1 20,403 28,358 40,595 34,144 28,313 28,483 28,393 28,358
P/E ratio 35.3 x 45.8 x 51.8 x 37.6 x 33.8 x 32 x 28.3 x 24.8 x
Yield - - - - - - - -
Capitalization / Revenue 6.42 x 8.79 x 10.5 x 8.22 x 6.94 x 6.92 x 6.55 x 6.28 x
EV / Revenue 6.78 x 9.19 x 10.9 x 8.71 x 7.47 x 7.44 x 7.03 x 6.72 x
EV / EBITDA 25 x 32.1 x 36.8 x 27.6 x 23.6 x 23.2 x 21.4 x 20.1 x
EV / FCF 40.3 x 44.9 x 50.7 x 46.3 x 32.9 x 32.9 x 31.1 x 28.8 x
FCF Yield 2.48% 2.23% 1.97% 2.16% 3.04% 3.04% 3.22% 3.47%
Price to Book 45.5 x 97.6 x 232 x 1,311 x -177 x -147 x -146 x -415 x
Nbr of stocks (in thousands) 24,354 23,795 22,986 22,294 21,684 21,388 - -
Reference price 2 793.3 1,140 1,697 1,445 1,213 1,238 1,238 1,238
Announcement Date 2/6/20 2/4/21 2/10/22 2/9/23 2/8/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,009 3,085 3,718 3,920 3,788 3,829 4,041 4,220
EBITDA 1 817.1 882.8 1,103 1,239 1,201 1,229 1,327 1,414
EBIT 1 778.1 840.7 1,058 1,192 1,152 1,167 1,260 1,339
Operating Margin 25.86% 27.25% 28.45% 30.42% 30.41% 30.48% 31.18% 31.73%
Earnings before Tax (EBT) 1 681.4 748.7 949.4 1,071 973.7 1,066 1,153 1,230
Net income 1 561.1 602.7 769 872.5 788.8 833 920.2 996.4
Net margin 18.65% 19.54% 20.68% 22.26% 20.82% 21.75% 22.77% 23.61%
EPS 2 22.47 24.91 32.78 38.41 35.90 38.69 43.77 49.98
Free Cash Flow 1 506.1 632.2 801.2 737.8 860.6 865 914.1 984.5
FCF margin 16.82% 20.49% 21.55% 18.82% 22.72% 22.59% 22.62% 23.33%
FCF Conversion (EBITDA) 61.94% 71.62% 72.66% 59.54% 71.66% 70.38% 68.88% 69.64%
FCF Conversion (Net income) 90.2% 104.89% 104.2% 84.56% 109.1% 103.85% 99.35% 98.81%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/6/20 2/4/21 2/10/22 2/9/23 2/8/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 952 1,037 897.8 978.4 985.8 1,058 928.7 982.1 942.5 935 879.1 927.7 974.5 1,040 916.2
EBITDA 1 284 330.6 253.1 296.9 318.8 370.4 278.5 319.9 308.2 294.3 248.9 296.6 326.1 363.1 290.2
EBIT 1 272.8 319.1 241.2 285.4 307.2 358.6 266.5 307.7 278 281.8 232.6 275.2 308.6 350.4 247.4
Operating Margin 28.66% 30.76% 26.87% 29.17% 31.16% 33.91% 28.69% 31.33% 29.5% 30.14% 26.46% 29.66% 31.67% 33.71% 27%
Earnings before Tax (EBT) - - - - - - - - - - - - - - -
Net income 1 203.7 230.9 174 212.1 220.6 265.8 188.4 213.9 201.6 184.8 160.2 194.5 218.5 258.8 177.4
Net margin 21.4% 22.26% 19.38% 21.68% 22.38% 25.13% 20.29% 21.78% 21.39% 19.76% 18.22% 20.97% 22.42% 24.9% 19.36%
EPS 2 8.710 9.940 7.550 9.290 9.760 11.86 8.470 9.690 9.210 8.520 7.410 8.944 10.18 11.90 8.471
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/4/21 2/10/22 5/5/22 7/28/22 11/3/22 2/9/23 5/4/23 7/27/23 11/9/23 2/8/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,083 1,240 1,583 1,919 2,011 2,003 1,913 1,877
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.326 x 1.405 x 1.436 x 1.548 x 1.675 x 1.629 x 1.442 x 1.328 x
Free Cash Flow 1 506 632 801 738 861 865 914 985
ROE (net income / shareholders' equity) 111% 171% 339% 889% - - - -
ROA (Net income/ Total Assets) 20.8% 21.5% 25% 25.6% 23% 27.7% 29.2% 33.4%
Assets 1 2,704 2,802 3,071 3,410 3,424 3,006 3,151 2,983
Book Value Per Share 2 17.40 11.70 7.310 1.100 -6.860 -8.450 -8.510 -2.990
Cash Flow per Share 2 24.20 29.90 38.70 37.80 44.00 45.30 48.90 55.90
Capex 1 97.3 92.5 108 121 105 124 113 123
Capex / Sales 3.24% 3% 2.89% 3.09% 2.78% 3.23% 2.8% 2.91%
Announcement Date 2/6/20 2/4/21 2/10/22 2/9/23 2/8/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Mettler-Toledo International, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
1,238 USD
Average target price
1,189 USD
Spread / Average Target
-3.99%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-1.93% 24.52B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. MTD Stock
  4. Financials Mettler-Toledo International, Inc.